Read More

Israeli ‘Cannabis Sticks’ Maker Reports Financial Results For 2023 Following Reverse Takeover

Israeli technology and cannabinoid company StickIt Technologies announced on Monday its financial results for the year ended Dec. 31, 2023. Revenue for the fiscal 2023 amounted to CA$203 000 ($149,300), compared to CA$564 000, in the prior year. The company called 2023 a "notable year" following the "completion of a reverse takeover on Oct. 23, 2023, positioning StickIt for accelerated growth and market expansion." Simultaneously the company completed a financing of CA$441,000, consisting of 1,024,628 subscription receipts for CA$0.4304 each, which were converted on a 1:1 basis into the company's common shares.StickIt, the developer exclusivity and patent protected of "Cannabis Sticks," debuted on the Canadian Securities Exchange (CSE), in the same month.

CSE:STKT

Read More

Female-Led California Weed Co. Gold Flora’s Net Loss Grows In Q4, Reports YoY Increase In Revenue & Gross Profit

Vertically-integrated California cannabis company Gold Flora Corporation announced on Friday its financial results for the three-month and twelve-month period ended Dec. 31, 2023. "We have strategically built a solid foundation consisting of premier indoor cultivation, and full vertical operations with deep consumer insights that have enabled our business to continue to expand its leadership position in California," Laurie Holcomb, CEO of Gold Flora, said. "This platform, combined with our focus on high-quality, profitable revenue streams has allowed us to capture more margin across every step of the supply chain and, as a result, we achieved positive adjusted EBITDA in the quarter, and improved our adjusted gross margin to approximately 66%, ahead of some of the leading multi-state operators in the industry.

GRAM

Read More

Flora Growth’s Stock Trading Higher On Pricing $3.2M Public Offering Of Common Shares

Flora Growth Corp. announced on Thursday the pricing of its underwritten public offering of 1.7 million common shares for aggregate gross proceeds of roughly $3.23 million. Clifford Starke, the company's CEO, and an existing investor have agreed to purchase, and have been allocated by Aegis Capital Corp., Common Shares in the offering. Flora said it will use the net proceeds from the transaction that is expected to close on or about Monday, April 8 for general corporate and working capital needs. The move came on the heels of the company's latest move to further cement its global footprint via acquisition in Germany.

FLGC